全文获取类型
收费全文 | 4797篇 |
免费 | 258篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 122篇 |
妇产科学 | 125篇 |
基础医学 | 711篇 |
口腔科学 | 41篇 |
临床医学 | 420篇 |
内科学 | 1283篇 |
皮肤病学 | 159篇 |
神经病学 | 449篇 |
特种医学 | 171篇 |
外科学 | 449篇 |
综合类 | 11篇 |
一般理论 | 1篇 |
预防医学 | 225篇 |
眼科学 | 63篇 |
药学 | 351篇 |
中国医学 | 7篇 |
肿瘤学 | 468篇 |
出版年
2023年 | 35篇 |
2022年 | 74篇 |
2021年 | 121篇 |
2020年 | 71篇 |
2019年 | 67篇 |
2018年 | 120篇 |
2017年 | 90篇 |
2016年 | 87篇 |
2015年 | 109篇 |
2014年 | 134篇 |
2013年 | 201篇 |
2012年 | 322篇 |
2011年 | 317篇 |
2010年 | 177篇 |
2009年 | 162篇 |
2008年 | 282篇 |
2007年 | 342篇 |
2006年 | 296篇 |
2005年 | 250篇 |
2004年 | 259篇 |
2003年 | 223篇 |
2002年 | 210篇 |
2001年 | 116篇 |
2000年 | 110篇 |
1999年 | 92篇 |
1998年 | 59篇 |
1997年 | 31篇 |
1996年 | 51篇 |
1995年 | 37篇 |
1994年 | 31篇 |
1993年 | 20篇 |
1992年 | 77篇 |
1991年 | 67篇 |
1990年 | 46篇 |
1989年 | 52篇 |
1988年 | 51篇 |
1987年 | 54篇 |
1986年 | 36篇 |
1985年 | 39篇 |
1984年 | 18篇 |
1983年 | 13篇 |
1982年 | 7篇 |
1981年 | 16篇 |
1980年 | 10篇 |
1979年 | 17篇 |
1978年 | 9篇 |
1976年 | 10篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1966年 | 7篇 |
排序方式: 共有5075条查询结果,搜索用时 15 毫秒
81.
82.
Transcriptional regulation of human sodium/iodide symporter gene: a role for redox factor-1 总被引:11,自引:0,他引:11
Puppin C Arturi F Ferretti E Russo D Sacco R Tell G Damante G Filetti S 《Endocrinology》2004,145(3):1290-1293
83.
Paolo Ortolani Antonio Marzocchi Cinzia Marrozzini Tullio Palmerini Francesco Saia Carlo Serantoni Matteo Aquilina Simona Silenzi Federica Baldazzi Daniele Grosseto Nevio Taglieri Robin M T Cooke Maria Letizia Bacchi-Reggiani Angelo Branzi 《European heart journal》2006,27(13):1550-1557
AIMS: Treatment delay is a powerful predictor of survival in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). We investigated effectiveness of pre-hospital diagnosis of STEMI with direct referral to PCI, alongside more conventional referral strategies. METHODS AND RESULTS: From January 2003 to December 2004, 658 STEMI patients were referred for primary PCI at our intervention laboratory. Three predefined referral routes were compared: (1) for patients within 90 min drive of the PCI centre, pre-hospital diagnosis and direct transportation (n=166), (2) diagnosis at the interventional hospital emergency department (n=316), (3) diagnosis at local hospitals before transportation (n = 176). Pre-hospital diagnosis was associated with more than 45 min reduction in treatment delay (P = 0.001). No significant difference in in-hospital mortality was apparent in the overall study population. In the cardiogenic shock subgroup (n = 80), pre-hospital diagnosis was associated with a two-thirds reduction in in-hospital mortality (P = 0.019); mortality was only 6.2% in shock patients who underwent PCI in < 2 h. CONCLUSION: This study shows that pre-hospital diagnosis can provide a reduction in primary PCI treatment delay, and suggests the hypothesis that this referral strategy might provide survival benefits to patients with cardiogenic shock. 相似文献
84.
Vignini A Nanetti L Moroni C Testa R Sirolla C Marra M Manfrini S Fumelli D Marcheselli F Mazzanti L Rabini RA 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2008,18(1):15-22
Background and aimType 2 diabetic (T2DM) patients show decreased fibrinolysis, mainly linked to high plasminogen activator inhibitor type 1 (PAI-1) production, together with a reduced bioavailability of nitric oxide and an impairment in Na+/K+-ATPase activity possibly involved in increased cardiovascular risk. Vitamin E is the major natural lipid-soluble antioxidant in human plasma. The present work was conducted in order to measure PAI-1, ICAM and VCAM-1 plasma levels, platelet nitric oxide production and membrane Na+/K+-ATPase activity in type 2 diabetic subjects treated with vitamin E (500 IU/day) for 10 weeks and then followed for other 20 weeks.Methods and resultsThirty-seven T2DM patients (24 males and 13 females) were studied. None of them were affected by any other disease or diabetic complications. Significant differences were detected for PAI-1 antigen (p < 0.001), PAI-1 activity (p < 0.001), nitric oxide (NO) production (p < 0.001), and Na+/K+-ATPase activity (p < 0.001) among the 4 phases of the study. A significant decrease both in ICAM and VCAM-1 plasma levels was also found at the 10th week compared with baseline (respectively p < 0.001 and p < 0.05).ConclusionOur data suggest that vitamin E counteracts endothelial activation in T2DM patients possibly representing a new tool for endothelial protection. 相似文献
85.
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor 总被引:1,自引:0,他引:1 下载免费PDF全文
Vannini A Volpari C Filocamo G Casavola EC Brunetti M Renzoni D Chakravarty P Paolini C De Francesco R Gallinari P Steinkühler C Di Marco S 《Proceedings of the National Academy of Sciences of the United States of America》2004,101(42):15064-15069
Histone deacetylases (HDACs) are a family of enzymes involved in the regulation of gene expression, DNA repair, and stress response. These processes often are altered in tumors, and HDAC inhibitors have had pronounced antitumor activity with promising results in clinical trials. Here, we report the crystal structure of human HDAC8 in complex with a hydroxamic acid inhibitor. Such a structure of a eukaryotic zinc-dependent HDAC has not be described previously. Similar to bacterial HDAC-like protein, HDAC8 folds in a single alpha/beta domain. The inhibitor and the zinc-binding sites are similar in both proteins. However, significant differences are observed in the length and structure of the loops surrounding the active site, including the presence of two potassium ions in HDAC8 structure, one of which interacts with key catalytic residues. CD data suggest a direct role of potassium in the fold stabilization of HDAC8. Knockdown of HDAC8 by RNA interference inhibits growth of human lung, colon, and cervical cancer cell lines, highlighting the importance of this HDAC subtype for tumor cell proliferation. Our findings open the way for the design and development of selective inhibitors of HDAC8 as possible antitumor agents. 相似文献
86.
Emanuele D’Amico Silvia Messina Cinzia Caserta Francesco Patti 《Expert opinion on drug safety》2015,14(7):1157-1168
Introduction: Daclizumab (DAC) is a mAb that binds to CD25, a receptor on the surface of lymphocytes for IL-2, a chemical messenger in the immune system. This prevents activation and proliferation of lymphocytes, which are involved in the immune attack in multiple sclerosis (MS).Areas covered: In this review, we will focus on newly emerging DAC-high-yield process (HYP) therapy for MS. Based on published original articles and citable meeting abstracts, we will discuss its mode of action as well as data on efficacy and safety.Expert opinion: DAC has been observed to have multiple (biological) effects, which may contribute to beneficial effects in immune-related disease and particularly in relapsing-remitting MS. The positive results in the clinical studies represent achievement of an important milestone in the development of DAC-HYP as a potential new treatment option for MS patients. The benefit/risk ratios of this new biological agent in MS therapy are still being evaluated. Soon, DAC-HYP might qualify as MS therapy. A safety monitoring program is recommended in the clinical practice. 相似文献
87.
Daniel M. Caruso M.D. Andrew A. Kassir M.D. Ramon A. Robles M.D. Michael W. Gregory M.D. Ryan B. Tsujimura M.D. Peter Cheung M.D. Peter J. Ferrara M.D. 《Diseases of the colon and rectum》1996,39(11):1222-1226
Introduction: Sigmoid volvulus is a disease of the elderly who often have severe comorbid conditions that increase their operative risk and limit treatment options. Conservative treatment with decompression
via
sigmoidoscopy with rectal tube placement has high success and recurrence rates. Surgical resection with primary anastomosis is the treatment of choice when decompression fails or if the volvulus recurs. Unfortunately, perioperative complications are frequent. Moreover, many patients with sigmoid volvulus are bedridden or incontinent of stool and do not benefit from extensive resection and maintenance of bowel continuity. METHODS: Twelve debilitated patients with sigmoid volvulus determined preoperatively to be poor candidates for laparotomy and reanastomosis were treated with a trephine stoma. Initially, each patient had decompression
via
rigid sigmoidoscopy and rectal tube placement. Surgical intervention consisted of formation of a small hole (trephine) in the left lower quadrant. Through this hole, a sigmoid resection and end colostomy were performed. No midline laparotomy was required. RESULTS: Operative times and analgesia requirements were significantly decreased (P
=0.05) compared with patients who underwent formal laparotomy. Length of hospital stay, complication rates, and length of bowel resected were similar using either surgical technique. CONCLUSIONS: The trephine stoma procedure offers significantly shorter operative times, with decreased perioperative morbidity. For high operative risk or debilitated patients with sigmoid volvulus, resection with end colostomy using the trephine stoma technique is the procedure of choice.Presented at the meeting of the Zollinger Surgical Society, Columbus, Ohio, September 5 to 7, 1996. 相似文献
88.
Laparoscopic resections for colorectal carcinoma 总被引:6,自引:3,他引:6
S. Alan Lord M.D. Dr. Sergio W. Larach M.D. Andrea Ferrara M.D. Paul R. Williamson M.D. Charles P. Lago M.D. Matthew W. Lube M.D. 《Diseases of the colon and rectum》1996,39(2):148-154
Laparoscopic resection for carcinoma of the colon and rectum is currently under intense scrutiny. PURPOSE: The purpose of this study is to review our three-year experience of laparoscopic surgery for colon and rectal carcinoma. METHODS: From October 1991 to September 1994, 76 laparoscopic procedures were performed for colorectal neoplasia (32 males and 44 females; mean age, 69 years). Fifty-five procedures were done for carcinoma, 16 for large polyps, and five for diversion in patients with unresectable cancer. For resectable tumors, the average size was 4 cm; staging was as follows: Dukes A, 10 patients; Dukes B1, 11; Dukes B2, 18; Dukes C1, 1; Dukes C2, 9; and Dukes D, 8. Fourteen cases (25 percent) that were converted to open procedures were compared with the 41 cases that were completed laparoscopically for differences in tumor size, surgical margins, number of lymph nodes harvested, length of hospital stay, and evidence of recurrence. Procedures completed laparoscopically were then compared with a group of open controls completed during the same time period. RESULTS: During the first six months, the conversion rate was 32 percent but dropped to 8 percent in the last six months. There were a total of 19 complications (25 percent), of which 8 (14 percent) were directly related to the laparoscopic technique. The mean number of lymph nodes harvested in laparoscopic resection for carcinoma was 8.5, and the average closest tumor margin was 4.5 cm. When laparoscopic resections were compared with converted and standard open colectomies, there was no significant difference in tumor margins or numbers of nodes resected. Length of stay was significantly shorter for anterior resections completed laparoscopically than for converted or conventional colectomies. Although this was also the trend for right hemicolectomies, it did not reach statistical significance. Mean follow-up of the group completed laparoscopically was 16.7 months, during which there was one recurrence. There were no trocar site recurrences. CONCLUSIONS: This early experience seems to indicate that laparoscopic surgery for colorectal carcinoma does not per se compromise surgical oncologic principles and encourages us to continue our critical appraisal of this technique.Read at the meeting of The American Society of Colon and Rectal Surgeons, Montreal, Quebec, Canada, May 7 to 12, 1995. 相似文献
89.
Manunta P Iacoviello M Forleo C Messaggio E Hamlyn JM Lucarelli K Guida P Romito R De Tommasi E Bianchi G Rizzon P Pitzalis MV 《Journal of hypertension》2005,23(9):1677-1681
OBJECTIVE: Impaired diastolic function and left ventricular hypertrophy can occur early in the natural history of essential hypertension. High circulating levels of endogenous ouabain (EO) have been described in essential hypertension and have also been associated with left ventricular hypertrophy. The aim of this study was to investigate whether these cardiac modifications are related to plasma EO levels in the offspring of hypertensive families. METHODS: The study involved 41 subjects with (FAM+) and 45 subjects without (FAM-) a family history of hypertension. Arterial blood pressure, left ventricular geometry and function, and plasma EO levels were measured in each subject. RESULTS: Plasma EO levels were higher in the FAM+ subjects (221.5 +/- 10.95 versus 179.6 +/- 9.58 pmol/l, P = 0.004), and directly correlated with both systolic (r = 0.417, P < 0.0001) and diastolic blood pressure (r = 0.333, P = 0.002). Plasma EO was inversely related to an index of cardiac diastolic function determined as the ratio between the early and late peak flow velocity (r = -0.286, P = 0.012) and isovolumetric relaxation time (IVRT) (r = 0.32, P = 0.003). The IVRT was also significantly higher in FAM+, correlated with the IVRT (r = 0.32, P = 0.003). The IVRT was also significantly higher in FAM+, whereas the other echocardiographic parameters were similar to FAM-. CONCLUSIONS: Among the offspring of families with a positive history of hypertension, circulating EO levels and blood pressure are increased. Plasma EO levels are related to alterations of some indexes of diastolic heart function in these individuals. 相似文献
90.
Jacob E. Resch Cathleen N. Brown Stephen N. Macciocchi C. Munro Cullum Damond Blueitt Michael S. Ferrara 《Journal of Athletic Training》2015,50(12):1292-1298
ContextSymptom presentation and recovery after sport concussion (SC) are variable. Empirically based models documenting typical symptom duration would assist health care providers in managing return to play after SC.ObjectiveTo develop a prediction model for SC symptom duration.DesignCross-sectional study.SettingTwo National Collegiate Athletic Association Division I university laboratories.Intervention(s)Participants completed the Revised Head Injury Scale (HIS-r), Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), and Sensory Organization Test within 24 hours of SC diagnosis.ResultsThe final formula consisted of the HIS-r''s self-reported neck pain, drowsiness, tingling, and nervousness duration and ImPACT total symptom severity (R = 0.62, R2 = 39%, R2adj = 34.2%, P < .001). Approximately 29% (R2cv = 29%) of the variance associated with total days symptomatic after SC was explained by our preliminary formula when cross-validated. The current formula correctly identified 76% of participants who recovered within 10 days of injury.ConclusionsOur results suggest that self-reported duration of 4 symptoms during the initial 24 hours after injury along with total symptom severity as measured by ImPACT accounted for a considerable amount of variance associated with days symptomatic after SC in collegiate athletes. Until the formula is cross-validated in a college-aged sample, caution is warranted in using it clinically.Key Words: traumatic brain injuries, prediction, prolonged recovery, symptom severity, symptom duration
Key Points
- A formula to predict symptom resolution after sport concussion primarily consisting of initial symptom duration and severity correctly identified 76% of National Collegiate Athletic Association Division I collegiate athletes who recovered within 10 days.
- Before it can be used clinically, the formula must be cross-validated on larger samples.